# Philisiwe B. Makhoba, M.D. – FDA Inspection, May 16, 2025

Source: https://www.keypedia.com/records/fda_inspections/philisiwe-b-makhoba-md/4f532f93-39f7-4922-8a3b-8a2284457b23
Source feed: FDA_Inspections

> FDA inspection 1271912 of Philisiwe B. Makhoba, M.D., May 16, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1271912
- Company Name: Philisiwe B. Makhoba, M.D.
- Inspection Date: 2025-05-16
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/andrace-deyampert/cdb4f833-488b-42b9-abab-4216435bce4c)
- [Issuing Officer](https://www.keypedia.com/people/samson-o-oluseye/bfe102f5-25cb-4ed9-9e69-2ec5ec0a047f)

Company: https://www.keypedia.com/companies/philisiwe-b-makhoba-md/28d9084e-4411-4cc5-aabe-0f10dcf3c0da

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c